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ABSTRACT 
Arsenic is found as a contaminant of drinking water, rice, and other crops. 
Epidemiological studies have shown that embryonic exposure to arsenic can cause 
changes in behavior and reductions in growth, but the mechanisms for these effects are 
not well understood.  So, we were interested in examining potential mechanisms by 
which arsenic could be affecting growth.  Additionally, while many studies have looked 
at higher levels of arsenic exposure, we wanted to focus on environmentally-relevant 
levels to see if these concentrations could have lasting consequences on growth, even 
after the exposure had ended.  
 Killifish (Fundulus heteroclitus) were used as the model organism for this 
investigation for two reasons.  First, they produce a large number of eggs, which can 
increase statistical power when observing affects over multiple time points.  Second, 
earlier studies have shown effects on developmental processes at arsenic levels similar to 
human exposures.  In rodent or zebrafish models, investigators typically need to use 
arsenic concentrations that are 100X higher to see similar effects.  Thus, killifish were 
exposed to 0, 10, 50, and 200ppb arsenic (as sodium arsenite) as embryos, and after 
hatching were reared in clean water until adulthood at 28 weeks.  The study was designed 
to represent a full embryonic/fetal arsenic exposure in utero, and then to examine whether 
effects persisted, worsened, or resolved into early adulthood.  We found that growth, 
assessed by condition factor (weight/length3), was significantly reduced by 24% in the 
200 ppb embryonic exposure groups at 8 weeks, with a dose dependent decrease in the 10 
and 50 ppb groups.  These trends persisted up to 28 weeks, although variability was much 
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higher. As we had seen similar reductions in growth in a previous embryonic arsenic 
exposure study that used higher arsenic concentrations, we therefore investigated three 
potential mechanisms responsible for the growth reduction.  
First, we analyzed feeding behavior, as it has been found to correlate to amount of 
nutrient intake.  Embryonic arsenic exposure did indeed reduce the percentage of fish 
initially responding to food and increased the amount of time it took for the fish to start 
their response, particularly at the 28 week time period.  So, one possibility is that arsenic 
reduces activity or alters olfaction, thus reducing their response to food.  The second 
mechanism examined was whether embryonic arsenic exposure altered the morphology 
of the intestine, or altered several specific cell types needed for nutrient uptake.  There 
was a slight, but statistically significant reduction in intestinal villus height at 16 weeks, 
this change did not persist.  Intestinal enterocytes and Goblet cell number, as measured 
by immunohistochemistry, did not change with arsenic concentration or time.  However, 
the number of PCNA-positive intestinal cells, indicating cell proliferation, was reduced in 
a dose-response manner at all sampling time points.  This may indicate that embryonic 
arsenic exposure permanently altered the ability of intestinal stem cells to proliferate. 
The third possibility we examined was whether embryonic arsenic exposure 
altered the expression of skeletal and hepatic insulin like growth factor (IGF-1), its 
receptor (IGFR-1) on skeletal muscle cells, and its associated binding proteins (IGFBP-1 
& -5) in the muscle and liver.  We hypothesized that changes in their levels might alter 
growth and muscle body weight, since epidemiological studies have found an inverse 
relationship between arsenic and IGF-1 in plasma levels, which correlate to reductions in 
iv 
birth weight.  Reductions of hepatic IGF1 and IGFBP-1 are highly correlated with 
condition factor reductions in the 8 week old fish.  However, by 28 weeks, hepatic IGF-1 
and IGFBP-1 still remain tightly correlated, but are actually increased in a statistically 
significant, dose-response manner.  This might be a compensatory response to potentially 
making up for any growth deficits seen in earlier stages.  
Overall, the results from this study show that embryonic-only arsenic exposure 
can alter growth factor expression, such as hepatic IGF-1, which correlates with a 
reduction in condition factor during an essential growth period such as the juvenile stage.  
As the fish reach sexual maturity, it appears that by increasing levels of IGF-1 and 
restoring a consistent intestinal environment, they are able to compensate for early 
growth deficits after embryonic exposure to lower levels of arsenic. 
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CHAPTER ONE 
LITERATURE REVIEW 
Purpose of the study 
In this study, our main objective is to determine whether arsenic exposure (10, 50, 
and 200ppb) during early life stages reduces growth and alters feeding behavior long 
after the exposure has ended, using killifish (Fundulus heteroclitus) as a model organism. 
Arsenic species and occurrence in the environment 
Arsenic (As) is a naturally occurring element found all over the world that has 
known toxic effects on animals1. The degree of toxicity can depend on the As species, 
since studies have shown that inorganic iAs (arsenite AsIII & arsenate AsV) as well as 
GSH-mediated methyl organic metabolites (methylarsonate and dimethlyarsinate)2 can be 
toxic 3,4. Arsenite and arsenate are most commonly found in aqueous environments due to 
the weathering of rocks with arsenic sulfides, mining activity, combustion of fossil fuels, 
which then interconvert from AsIII & AsV in an aqueous environment depending on pH 
and redox conditions3,5. Since arsenite predominates in reducing anaerobic environments, 
it is the form commonly found in groundwater6.  Other organic arsenic species include 
arsenobetanine, arsenosugars, and arsenocholine.  Exposures to them are typically 
through the diet, as they are commonly found in fish, shellfish, and poultry growth feed 
additives (Rocxarsone)4,7,8.  These forms have been found to be generally nontoxic2. In 
addition, arsenic can form mono-, di-, and trimethylated metabolites. The different 
oxidation states and chemical structure of arsenic species can correlate to its 
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cytotoxicity9.  For example, one study found that some human cells (hepatocytes, 
keratinocytes, and bronchial epithelial cells) are more sensitive to cytotoxic effects of 
MMAIII10 compared to inorganic AsIII 11.  Another study found that DNA damage in 
human hepatocytes and urotheial cells is induced primarily induced by MMAIII and 
DMAIII 12. 
 
Geographic arsenic water exposure  
Throughout history and in the present day, arsenic has been used for industrial 
and agricultural purposes such as the manufacturing of car batteries, alloyed 
semiconductor materials, and as a pesticide13, as well as being, used as an effective drug 
for treatment of acute promyelocytic leukemia (APL) 9.  However, the major source of 
human exposure to arsenic is through drinking water.  In the past 10 years, China alone 
has experienced at least 4 major arsenic water contamination accidents through ill-
managed industrial waste discharge in the following water sources:  620 µg/L in 
Xinqiang River, 570 µg/L in Duliu Creek, 180 µg/L in Yangzonghai Lake and 530 µg/L 
in Dashahe River3.  While the U.S. EPA drinking water standard is 10ppb (10µg/L), 
higher levels can be found in private wells, which are often unregulated.  These higher 
levels of arsenic raise concern for roughly 13 million U.S households14.  It was estimated 
that 42.7 % of aquifers in the southwestern part of the U.S had greater than 10µg/L15.  
Other parts of the U.S also have elevated arsenic levels.  For example, 8% of wells 
measured in Pennsylvania had concentrations > 10 µg/L 16, New England found that 30% 
of wells had > 10 µg/L 17, North Carolina found around 1,436 wells out of 63,000 with 
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levels higher than 10µg/L (maximum was 806µg/L) 15 and well water in Arizona can be 
up to 61µg/L18. Additionally, arsenic pollution of water has been reported in 
epidemiological studies in other countries including Chile (up to 110 µg/L As) 19, 
Bangladesh (0.1-864 µg/L As) 20, Taiwan (<0.1-347.43 µg/L As) 21, and Hungary (0-50< 
µg/L As)22 to list a few.  
 
Dietary arsenic exposure  
Not only are people exposed through their water supply, but arsenic has been 
found in dietary sources.  According to the European Food Safety Authority, the main 
competent to the dietary exposure to iAs comes from grain-based processed products 
such as wheat bread and rolls in adults, while infant and toddler exposures were from 
rice, milk, and dairy products23. The mean dietary exposure in infants and toddlers ranged 
from 0.20-2.09 µg/kg body weight/day, while adults ranged from 0.09-0.64 µg/kg body 
weight/day21.  In fish and seafood, there are usually greater amount of arsenobetaine and 
arsenocholine, both of which have a lower potential for toxicity to humans23.  Arsenic is 
easily taken up into major food sources such as rice, which has been shown to accumulate 
inorganic arsenic at a 10-fold high rate than other grains 24.  One study examining arsenic 
concentrations in various types of rice found levels of 200 µg /kg in brown rice, 130 µg 
/kg in white rice, and 70 µg /kg in other color rice 25,26.  Another study conducted a 
product test investigating arsenic content in 9 different rice-based infant snacks found 
ranges from 36.5-568 ng/g total As27.  
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A report in the U.S looking at dietary consumption patterns found that in some 
infant formulas, infants could be exposed on average to 9.4-14 µg/day iAs when 
consuming formulas using brown rice syrup as a healthy alternative to sugar. This study 
also found adults consuming rice could be exposed to an average to 11 µg/day iAs28.  
Based on epidemiology studies, arsenic exposure between 0.3 and 8 µg/kg body 
weight/day was estimated to result in a 1% increased risk of lung skin and bladder tumors 
in humans23.  A recent European study looking at the need for arsenic risk reduction 
deduced that based on a daily consumption of 2L of water a day at 10 µg/L arsenic by a 
person weighing 70 kg equals 0.3µg/kg body weight/day which is in the 1% benchmark 
does range for carcinogenesis23.  Additionally, the U.S. Agency for Toxic Substances and 
Disease Registry’s (ATSDR) Minimal Risk Levels (MRLs) for acute oral consumption at 
5µg/kg/day and chronic oral consumption at 0.3µg /kg/day arsenic as safe doses for 
infants28. In order to reduce the risk of cancer later in life for infants’ minimizing and 
regulating the amount of arsenic exposure through diet and water is essential. 
 
Naturally-occurring and anthropogenically-introduced arsenic sources continue to 
raise the need for further investigation not only for arsenic remediation efforts but also 
the mechanisms behind its toxic effects on animals. Furthermore, since studies have 
shown that arsenic exposure in animals can contribute to cancer, behavior and cognitive 
dysfunction, as well as impaired growth and development, it is extremely important to 
investigate arsenic’s effects at early life stages29. It is also essential to understand the 
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metabolism of arsenic and what species could potentially increase harmful developmental 
effects.  
 
Arsenic biotransformation in animals 
In animals, arsenic (iAsV and iAsIII) is absorbed from the intestine and is typically 
metabolized through a specific biotransformation pathway usually occurring in the liver.  
It can enter a cell via aquaporins and is later exported, in part, through membrane bound 
efflux transporters (MRPs) 5. The metabolism of iAs happens through a series of 
oxidative methylation and reduction reactions that promotes As excretion in urine5.  For 
example, inorganic arsenic AsIII goes through oxidative methylation along with 
conjugation of GSH to convert it into monomethyl arsenic or MMAv.  MMAv is reduced 
to MMAIII which undergoes oxidative methylation to form dimethylated arsenic or DMAv 
by an S-adenosylmethionine -dependent enzyme termed arsenic methyltransferase 
(As3MT) 4,30,31.  The reduction of pentavalent As to trivalent As is usually mediated by 
an arsenate reductase enzyme with the addition of a methyl group5. Figure A. shows a 
general arsenic biotransformation pathway.   
 
 
 
 
 
 
Figure A. General arsenic biotransformation pathway. Modified from Casarett and 
Doull’s Toxicology 8th edition.  
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All forms of arsenic - Asv, AsIII, MMA, and DMA can be detected in urine, with 
DMA being the most commonly detected species5,32. These methylation pathways have 
been seen in aquatic animals such as fish with metabolism usually occurring in the gills 
and liver, but they have a greater tendency to accumulate arsenobetanine and 
arsenocholine which are thought to be less toxic forms5. While methylation of iAs is an 
attempt at detoxification, it can also be a bioactivating pathway that leads to greater 
toxicity as studies have found that the intermediate trivalent methylated arsenicals 
(MMAIII and DMAIII) can be more effective inhibitors of enzymes, and cause more 
cytotoxicity and genotoxicity than iAs5,33.  
 
Growth and intestinal development in mammals 
As previously mentioned, arsenic and its metabolites can impair growth and 
development.  In order to understand these effects, it is first important to understand 
normal animal development. In mammals after sperm entry into the egg, the first 
cleavage begins about a day later and the two nuclei produced by this cleavage are the 
first to contain the entire genome.  During cleavage events, the zygotic genome is 
activated at different times depending on the species; human zygotic genes, genes 
transcribed by the zygote’s DNA, are activated at the 8- cell stage, whereas mouse and 
goat zygotic genes can be activated in late zygote stage and continue through 2-cell stage. 
In order for zygotic genes to be activated, parental chromatin undergoes changes and 
gamete-specific methyl groups on DNA are removed unless imprinted, and new DNA 
methylation patterns are established. By the 8-cell stage, the genome of each cell is 
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hypomethylated and appear to be pluripotent which sets the stage for cell differentiation 
to occur34. 
 
The blastocyst contains trophoectoderm cells which will give rise to 
extraembryonic tissues like the chorion around day 10-12 in humans, and an inner cell 
mass with pluripotent cells which will give rise to the embryo. The inner cell mass then 
delaminates into the epiblast, which becomes the three germ cell layers during 
gastrulation. Around day 12-15, the primitive streak is formed, which goes on to form 
embryonic mesoderm (giving rise to muscles, skeleton, connective tissue, reproductive 
organs, kidneys, and circulatory structures) and endoderm (gives rise to the 
gastrointestinal tract, lining of respiratory tract, and organs like the liver and pancreas) 
while the embryonic epiblast forms the embryonic ectoderm (gives rise to the nervous 
system)34. After the completion of gastrulation, organogenesis begins around 5 weeks in 
humans.  
 
As previous studies in our lab have noticed a reduction in growth of killifish 
exposed to arsenic as embryos, we wanted to determine if arsenic might have an effect on 
intestinal development, potentially leading to a reduction in nutrient uptake and growth.  
The endodermal function in the embryo is to construct the linings of the digestive tube, 
which is signaled by the Sox17 transcription factor that is necessary for gut endoderm 
morphogenesis35.  The digestive tube constricts to form the esophagus followed by the 
stomach, small intestine, and large intestine, and then puts out branches that become the 
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thyroid, thymus, pancreas, and liver36. Gut tissue forms by reciprocal interactions 
between endoderm and mesoderm. Signals playing a role in specification of the gut tube 
are typically in gradients and Wnt is thought to be important in this process36. Wnt 
signals, which are instructed by RA (retinoic acid) and FGF gradients from posterior 
mesoderm, induce the posteriorizing transcription factors Cdx1, Cdx2 as well as 
paracrine factor Indian hedgehog that play a role in intestine formation. At high 
concentrations, Cdx1 and 2 induce the formation of the large intestine, and at low 
concentrations, they induce the formation of the small intestine36. In the anterior region of 
the gut tube, which forms thymus, pancreas, stomach, and liver, Wnt signaling is 
blocked.  In the stomach forming area, the gut tube mesenchyme lining expresses 
transcription factor Barx1 which turns on Frzb-like Wnt-blocking proteins. In a study 
observing intestinal development in mice showed that villi form around embryonic day 
15 and the crypts, where stem cells reside, were set up shortly after birth due to the 
expression of Hedgehog. Growth of the villus is promoted by BMP2 and 437. The 
morphogenesis of villi and crypts occur by folding of the endodermal epithelium and 
depends on the decreased expression of ephrin B1 in villi and increased ephrin B2 and 3 
in the crypts where β-catenin plays a role in repression and up regulation of these 
proteins, respectively37. Additional studies on mice have found that cells expressing adult 
intestinal stem cell markers such as Lgr5, Ascl2, and Olfm4 appear around embryonic 
day 15 and reside in the inter-villus region, suggesting that Wnt-dependent progenitors of 
adult intestinal stem cells are established prior to birth38. In this study, they found that 
Lgr5 progenies give rise to all differentiated intestinal epithelial cell types including; 
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enterocytes, enteroendocrine, goblet, and Paneth cells38. The enterocytes are the most 
abundant intestinal epithelial cells, making up to about 80% of all epithelia cells. They 
function in increasing the absorptive surface, and have hydrolytic and absorptive 
functions to take up and degrade nutrients39. In mice, the turnover rate for enterocytes is 
estimated to be around 3 days. Goblet cells represent about 5% of the epithelial cells and 
contain mucus that constitutes a barrier against the intestinal contents. Turnover for 
goblet cells is around 3 days as well. Enteroendocrine cells make up a much smaller 
percentage of the intestinal epithelial cells and they produce hormones that help in 
regulating gastrointestinal motility. Paneth cells function mostly in antimicrobial defense 
of the intestine, roughly 10 Paneth cells are present per crypt, and they and have a slower 
turnover rate of about 20 days39.  
 
The rapid cell division in crypts is dependent upon Wnt/β-catenin signaling37. The 
stem cells divide rapidly into progenitor cells in the intestine then take on their fate based 
on signals from genes such as Math1 (aka Atoh1)40, which promotes the fate of secretory 
(goblet and endocrine) cells along with a decrease in Notch41. Whereas the Notch ligand 
Delta turns on transcription factors such as Hes-1 to specify enterocyte fate41.  Below is a 
general diagram of these signals and the fate of the stem cell in Figure B. 
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As embryonic development is complete and the fetus is growing, in utero 
signaling pathways such as insulin-like growth factor (IGF-1) is extremely important for 
growth. In humans serum IGF-1 concentration from 15-37 weeks of gestational age there 
is a positive correlation with IGF-1 concentration and fetal weight and bone length42. 
Similarly, umbilical cord IGF-1 levels reflect fetal IGF-1 levels at birth and decreased 
IGF-1 levels correlate with a decrease birth weight in humans. There has also been 
evidence that IGF-1 is detectable in fetal tissue in the first trimester suggesting IGF-1 
might play a role in early development42.  Similar to mammals, IGF-1 signaling plays a 
Figure B. Signals involved in the intestinal crypt based columnar cell (CBC) and 
Lgr5 marked stem cell fate. Modified image from (Boaz et al., 2014) 
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role in juvenile fish development, providing evidence of its significance for normal 
growth43.   A general diagram of IGF-1 signaling pathway located in Figure C.  
 
Growth and development in fish 
My work uses killifish (Fundulus heteroclitus) as model organisms.  Fish eggs are 
telolecithal meaning the majority of the egg cell cytoplasm is occupied by yolk44. 
Cleavage can only occur in a thin region of the yolk free cytoplasm called the blastodisc. 
The first cell divisions after fertilization have a reproducible pattern of meridional and 
equatorial cleavage. Fish embryos undergo mid-blastula transition, which is when zygotic 
gene transcription begins around the 10th cell division.  At this time three distinct cell 
populations develop: the yolk syncytial layer (role in directing cell movements of 
gastrulation), the enveloping layer which is a protective covering that allows the embryo 
to develop in hypotonic solutions, and the deep cells which give rise to the embryo 
proper44.  
During gastrulation, all three layers undergo epiboly, the movement of epithelial 
layers that spread to enclose the deeper layers of the embryo, and progress through it until 
the entire yolk cell is covered by the blastoderm44. Once the blastoderm has covered 
about half the yolk cell, a thickening occurs referred to as the germ ring which is made of 
the epiblast (later to be the ectoderm) and the hypoblast (later to be the endoderm and 
mesoderm). The endoderm expresses casanova (Sox 32) and spiel-ohne-grenzen (Oct 4) 
genes controlled by nodal which will become intestine, liver, and pharynx.  Mesoderm 
expresses genes like notail (brachyury) and spadetail (Tbx6 and VegT) which will 
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Figure C. IGF-1 Signaling pathway to 
promote cell proliferation.  
become heart, muscle, head, blood, and fins45.  Ectoderm expresses BMPs and certain 
Wnt proteins which will become epidermis, brain, nose, 
eye, and spinal cord.  Once organogenesis is complete and 
the fish continues to grow to adulthood, signaling 
pathways such as IGF play a role in growth by promoting 
proliferation and differentiation of growing tissue, similar 
to fetal growth in humans. As shown in Figure 2, IGF 
binds to specific receptors on the cell surface of growing 
tissue to mediate proliferation.  It can also bind to IGF 
binding proteins (IGFBPs) that have various functions, 
depending on the tissue type and the health status of the 
organism46. The binding proteins can aid in the control of 
IGF distribution between extracellular environments and cell surface binding sites, and 
may also regulate IGF bioactivity by modulating its interaction with the receptor46.  For 
example, like growth factor binding protein-1 (IGFBP-1) is found predominantly in the 
liver and inhibits the bioavailability of IGF typically under stressful conditions47. In one 
study in zebrafish, they found that under times of starvation, IGFBP-1 was significantly 
increased47. In contrast, IGFBP-5 located primarily in the muscle is considered pro-
myogenic and increases the bioavailability of IGF during myoblast differentiation playing 
an important role in fish muscle growth48. Additionally, other factors related to the 
gastrointestinal systems play a role in fish growth such as peptide transporters located on 
enterocytes and part of the brush border membrane. They play a major role in animal 
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growth through amino acid transport and availability.  Peptide transporter 1 (PEPT1) is 
primarily involved in the uptake of dietary protein degradation products and fish 
growth49. In studies using PEPT1 knockout mice, body weight was reduced and 
microvilli were shortened50.  
 
Intestinal development and stem cell signals in fish 
Intestinal development in fish is like that of mammals. While not much 
investigation has been done on killifish intestinal development, its development in 
zebrafish has been thoroughly investigated. One study found that the intestinal tract has 
undergone extensive remodeling around the fourth day of development, along with 
compartmentalization into three main segments: the intestinal bulb, mid-intestine, and 
posterior intestine, which will be composed of cells that will perform specialized 
functions51.  These specialized cells consist of enteroendocrine cells, which are hormone 
secreting cells observed 52-76 hours post fertilization, goblet cells, which secrete 
mucous, and enterocytes, which are absorptive cells, both observed 76-126 hours post 
fertilization.  After 5 days of development, epithelial folding is more extensive in the 
intestinal bulb while mid- and posterior intestine remain unfolded and the presence of 
goblet cells and enterocytes is restricted to the mid-intestine. The folding processes 
proceeds rostrocaudally, as it does in mammals, with folding in the mid-intestine 
appearing around 8 days and folding in the posterior intestine appearing around 12 
days51. The morphological characteristics of the intestinal bulb represent tall fold (plicae) 
or villus like extensions, which become progressively shorter through the mid to posterior 
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intestine.  Although zebrafish and other minnows lack crypts where stem cells reside, 
they do have proliferative compartments at the base of the villus-like folds 51.   
 
Differentiation of intestine stem cells in zebrafish is dependent on the same 
pathways and signals seen in mammals.  Delta, the Notch ligand, accumulates in 
secretory cells of zebrafish gut and activates the Notch cascade in neighboring cells, 
which turns on transcription factors (Hes-1) specifying enterocyte fate, in part due to the 
repression of Ascl1a.  Ascl1a is a gene that plays a role in specification of goblet and 
enteroendocrine cells52.  Like mammals, epithelial cells in zebrafish migrate from the 
base of the intestinal folds to the tip of the fold within 5-7 days in the anterior intestine 
and 7-10 days in the mid intestine. Mechanisms driving differentiation of epithelial cells 
towards the secretory lineage (goblet cells or enteroendocrine) seems to be highly 
conserved in vertebrates and dependent on Delta-Notch signaling41, 53, 54.  Interestingly, 
previous studies in our lab looking at arsenic’s effects on neuronal cell differentiation 
found that arsenic exposure decreased Ascl1 expression by 2.5-, 7-, and 4-fold on days 5, 
7 and 9 of stem cell differentiation.  An increase in Ascl1 expression has been shown to 
promote neuronal differentiation, so decreased expression could be a mechanism by 
which arsenic inhibits stem cell differentiation55.  As stated above, Ascl1a also plays role 
in intestinal stem cell differentiation, which suggests that it may also be reduced in the 
intestine of embryonically exposed killifish, and therefore reduce intestinal cell 
development. Therefore, arsenic exposure during development is a major concern. 
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Arsenic’s effect on growth and development 
It is known that arsenic can easily cross the placental barrier 29.  A study in 
Bangladesh investigated levels of arsenic in maternal and cord blood of pregnant women 
who were drinking water with of 90.5μg As/L which is much higher than the 10μg/L 
standard set by the WHO56. They found that arsenic levels in the maternal blood 
(11.7μg/L) and cord blood (15.7μg/L total arsenic) were similar, indicating that the fetus 
was also readily exposed to arsenic levels that could interfere with growth and 
development56.  A mass poisoning event occurred in 1955 in Japan where bottle-fed 
infants were exposed to about 500μg arsenic/kg body weight through their formula 
(Morinaga milk powder) and led to more than 100 infant deaths. Infants less than 12 
months of age had symptoms of anorexia, skin pigmentation, diarrhea, vomiting, fever, 
and abdominal distention which was first misdiagnosed as bronchitis or pneumonia until 
the link between patient’s dried milk brand and arsenic content was made57,58. This event 
raised a need to investigate arsenic’s long term effects following an early life-stage 
exposure.  Another study followed the arsenic exposed infants 50 years later, and found 
among 50 individuals their average height was 6.5 cm below the control group indicating 
there might be potential for abnormalities in proper skeletal growth due to early life 
arsenic exposure59. Another study looked at neurological issues in these patients and 
found that the group exposed as infants to arsenic exhibited neuropsychological deficits 
such that they showed an average performance of at least 1.2 standard deviations below 
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the average for the control unexposed group in memory tests57, had drastically reduced 
IQs, and increases in central nervous disorders like epilepsy and mental retardation58 
Other studies have found reductions in birth weight and gain following in infants exposed 
in utero to arsenic.  For example, a study in Bangladesh examining low level arsenic 
exposure (<100ppb) during pregnancy found a significant decrease in birth weight, with 
each 1µg/L increase in urinary being associated with a 1.68 g reduction in birth weight60.  
A European study looking at prenatal exposure to chemical mixtures found that arsenic 
was the only chemical in the mixture to have a significant inverse correlation to babies’ 
birth weight, declining 90g as arsenic increased in cord blood samples61. Additionally, a 
study in Bangladesh found that with increasing arsenic levels, IGF-1 plasma levels were 
significantly decreased and correlated with reduced birth weight62.  Long term, in utero 
arsenic exposure has been associated with reductions in weight gain.  For example, a 
study in Bangladesh followed pregnant woman exposed to arsenic and cadmium. They 
found that the children at 5 years of age had a reduction in weight gain and height with 
41% of the children being underweight and 33% were stunted, and that these effects were 
most apparent in girls63.  
 
Similar findings have been seen in animal models.  In a study looking at the 
effects of dietary arsenic exposure in juvenile rainbow trout found that there was a 
significant 15 and 34% decrease in weight gain in fish that fed on oligochaetes exposed 
to 4.5mg/L and 8.2mg/L As respectively. The uptake of arsenic into these oligochaetes 
ranged from 35- 58µg As/g dry weight 64. A study looking at mice found that drinking 
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water arsenic exposure (10 ppb & 42.5 ppm) from gestational day 10 until birth was 
correlated with significantly greater body weight gain, fat content, and glucose 
intolerance through young adulthood65.  Moreover, a study looking at rats exposed to 100 
ppb arsenic during development plus a western style diet found an increase in body 
weight beginning at week 5 until the end of the study at week 15 66.  Not only are studies 
finding a reduction in weight at birth but they are also finding an increase in body weight 
later in life which some studies think this could be a result of diet66. As a handful of 
studies have shown that arsenic was correlated with a reduction in weight gain, it is 
crucial to begin to discover some of the underlying mechanisms involved. Arsenic has 
been analyzed in studies of weight gain and IGF-1 which could be a potential pathway of 
concern as IGF-1 is a major factor in growth and cell proliferation but it would also be 
interesting to investigate arsenics effects on the intestine as it is the primary organ of 
nutrient uptake which is essential for proper growth.  
 
Arsenic exposure and behavior 
Arsenic has also been shown to influence animal behavior, and alterations in 
feeding and the ability to detect and recall food in the environment could lead to changes 
in nutritional uptake, and decrease growth and survival.  A study discovered that 
weanling rats exposed to arsenic displayed an impairment in spatial memory after putting 
them through hidden platform acquisition tests and visible platform trials67. In this study, 
both adult and infant rats exposed to arsenic were tested using a variety of operant 
condition tests. The study found learning deficits and time required to learn a new task 
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was increased in rats exposed as infants compared the unexposed controls 67.  Another 
study looking at photo motor response as a behavioral assay in zebrafish embryos 
exposed to 900-1,000µM As found that the arsenic exposed embryos exhibited 
hypoactivity68. Additionally, a study reported that As at 0.75 mM impaired long term 
memory in avoidance training behavioral tasks, providing more evidence that arsenic 
could be affecting normal brain development and function as a neurotoxicant69.  
 
For fish, olfaction is crucial to behaviors such as finding food, selecting mates, 
migratory routes, and evaluating the risk of predation. An olfaction study in rainbow trout 
showed that metals, such as cadmium and copper, reduced the ability of rainbow trout 
olfactory epithelium to L-alanine and taurocholic acid70.  L-alanine mimic’s food 
detection and taurocholic acid should elicit a social response via olfaction70. This study 
demonstrates that exposure to metals can cause impairments of the olfactory response in 
fish, which could result in a variety of behavioral deficits such as food detection.   
We hypothesize that changes in feeding behavior in fish exposed to arsenic could be 
another potential mechanism for weight gain reductions.  
 
In humans, behavior related studies have focused more on arsenics effects on 
memory, IQ, learning, anxiety and depression. A meta-analysis study focused on 
arsenic’s effects on intelligence in children (5-15 years old) found that increases in 
urinary arsenic reduced IQ71, 72.  Additionally, a study in India looking at children (5-15 
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yrs) with an average lifetime arsenic exposure of 147µg/L found a 12-20% decrease in 
vocabulary, object assembly, and picture completion test score73.  
 
Hypothesis and rationale 
I hypothesize that arsenic exposure during embryogenesis results in a reduction in 
weight gain in our model species, killifish. The potential mechanisms that I will be 
examining are:  1) changes in feeding behavior 2) alterations in IGF signaling pathway 
expression, and 3) changes in intestinal morphology possibly interfering with nutrient 
uptake.  I hope the results from these data could help elucidate if the arsenic standard 
drinking water limit (10 ppb) is protective of proper embryo growth and development, 
and if there are any long-term consequences to exposures of environmentally relevant 
arsenic levels (50 and 200ppb).  
 
 
 
 
 
 
 
 20 
References 
1. Jomova K, Jenisova Z, Feszterova M, et al. Arsenic: Toxicity, oxidative stress and human 
disease. J Appl Toxicol. 2011; 31(2):95-107.  
2. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. 
Toxicology. 2011; 283:65.  
3. Zheng L, Liu Z, Yan Z, et al. Deriving water quality criteria for trivalent and pentavalent 
arsenic. Sci Total Environ. 2017; 587–588:68-74.  
4. Sattar A, Xie S, Hafeez MA, et al. Metabolism and toxicity of arsenicals in mammals. Environ 
Toxicol Pharmacol. 2016; 48:214.  
5. Ventura-Lima J, Bogo MR, Monserrat JM. Arsenic toxicity in mammals and aquatic animals: 
A comparative biochemical approach. Ecotoxicol Environ Saf. 2011; 74(3):211.  
6. Mohan D, Pittman C Jr. Arsenic removal from water/wastewater using adsorbents-A critical 
review. J Hazard Mater. 2007.  
7. Nachman KE, Baron PA, Raber G, et al. Roxarsone, inorganic arsenic, and other arsenic 
species in chicken: A U.S.-based market basket sample. Environ Health Perspect. 2013; 
121(7):818-824.  
8. Chung JY, Yu SD, Hong YS. Environmental source of arsenic exposure. J Prev Med Public 
Health. 2014; 47(5):253-257.  
 21 
9. Khairul I, Wang QQ, Jiang YH, et al. Metabolism, toxicity and anticancer activities of arsenic 
compounds. Oncotarget. 2017; 8(14):23905-23926.  
10. Petrick JS, Ayala-Fierro F, Cullen WR, et al. Monomethylarsonous acid (MMA(III)) is more 
toxic than arsenite in chang human hepatocytes. Toxicol Appl Pharmacol. 2000; 163(2):203-207.  
11. Styblo M, Del Razo LM, Vega L, et al. Comparative toxicity of trivalent and pentavalent 
inorganic and methylated arsenicals in rat and human cells. Arch Toxicol. 2000; 74(6):289-299. 
12. Dopp E, Recklinghausen Uv, Diaz-Bone R, et al. Cellular uptake, subcellular distribution and 
toxicity of arsenic compounds in methylating and non-methylating cells. Environ Res. 2010; 
110(5):435.  
13. Hyun Soo Kim*, Yeo Jin Kim*, Young Rok Seo. An overview of carcinogenic heavy metal: 
Molecular toxicity M echanism and prevention. Journal of Cancer Prevention. 2015; 20(4):232-
240. 
14. Flanagan SV, Spayd SE, Procopio NA, et al. Arsenic in private well water part of 3: 
Socioeconomic vulnerability to exposure in maine and new jersey. Sci Total Environ. 2016.  
15. Naujokas MF, Anderson B, Ahsan H, et al. The broad scope of health effects from chronic 
arsenic exposure: Update on a worldwide public health problem. Environ Health Perspect. 2013; 
121(3):295-302.  
16. Frederick L, VanDerslice J, Taddie M, et al. Contrasting regional and national mechanisms 
for predicting elevated arsenic in private wells across the united states using classification and 
regression trees. Water Res. 2016; 91:295.  
 22 
17. Ayotte JD, Montgomery DL, Flanagan SM, et al. Arsenic in groundwater in eastern new 
england: occurrence, controls, and human health implications. Environmental Science \& 
Technology. 2003; 37(10):2075-2083.  
18. Tsuji JS, Perez V, Garry MR, et al. Association of low-level arsenic exposure in drinking 
water with cardiovascular disease: A systematic review and risk assessment. Toxicology. 2014; 
323:78.  
19. Liaw J, Marshall G, Yuan Y, et al. Increased childhood liver cancer mortality and arsenic in 
drinking water in northern chile. Cancer Epidemiol Biomarkers Prev. 2008; 17(8):1982-1987.  
20. Chen Y, Graziano JH, Parvez F, et al. Arsenic exposure from drinking water and mortality 
from cardiovascular disease in bangladesh: Prospective cohort study. BMJ. 2011; 
342:10.1136/bmj.d2431.  
21. Liang C, Wang S, Kao Y, et al. Health risk assessment of groundwater arsenic pollution in 
southern taiwan. Environ Geochem Health. 2016; 38(6):1271-1281.  
22. Rudnai T, Sandor J, Kadar M, et al. Arsenic in drinking water and congenital heart anomalies 
in hungary. Int J Hyg Environ Health. 2014; 217(8):813-818.  
23. Gundert-Remy U, Damm G, Foth H, et al. High exposure to inorganic arsenic by food: The 
need for risk reduction. Arch Toxicol. 2015; 89(12):2219-2227.  
24. Azizur Rahman M, Hasegawa H, Mahfuzur Rahman M, et al. Arsenic accumulation in rice 
(oryza sativa L.): Human exposure through food chain. Ecotoxicol Environ Saf. 2008; 69(2):317-
324.  
 23 
25. Zavala YJ, Duxbury JM. Arsenic in rice: I. estimating normal levels of total arsenic in rice 
grain. Environ Sci Technol. 2008; 42(10):3856-3860. 
26. Diaz OP, Arcos R, Tapia Y, et al. Estimation of arsenic intake from drinking water and food 
(raw and cooked) in a rural village of northern chile. Urine as a biomarker of recent exposure. Int 
J Environ Res Public Health. 2015; 12(5):5614-5633.  
27. Karagas MR, Punshon T, Sayarath V, et al. Association of rice and rice-product consumption 
with arsenic exposure early in life. JAMA Pediatr. 2016; 170(6):609-616.  
28. Wilson D. Arsenic consumption in the United States. Journal of Environmental Health. 2015; 
78:3. 
29. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr. 2009; 29:381-399.  
30. Watanabe T, Hirano S. Metabolism of arsenic and its toxicological relevance. Arch Toxicol. 
2013; 87(6):969-979.  
31. Peters BA, Hall MN, Liu X, et al. Renal function is associated with indicators of arsenic 
methylation capacity in bangladeshi adults. Environ Res. 2015; 143(0 0):123-130.  
32. Middleton DR, Watts MJ, Hamilton EM, et al. Urinary arsenic profiles reveal exposures to 
inorganic arsenic from private drinking water supplies in cornwall, UK. Sci Rep. 2016; 6:25656.  
33. Yamanaka K, Kato K, Mizoi M, et al. The role of active arsenic species produced by 
metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Toxicol Appl 
Pharmacol. 2004; 198(3):385.  
 24 
34. Gilbert SF. Early mammalian development. In: Azelie Aquadro, Carol Wigg, Elizabeth C. 
Pierson, eds. Developmental biology. Tenth ed. Sunderland, Maryland USA: Sinauer Associates, 
Inc.; 2014:299-315. 
35. Viotti M, Nowotschin S, Hadjantonakis A. SOX17 links gut endoderm morphogenesis and 
germ layer segregation. Nat Cell Biol. 2014; 16(12):1146-1156.  
36. Gilbert SF. Endoderm. In: Azelie Aquadro, Carol Wigg, Elizabeth C. Pierson, eds. 
Developmental biology. Tenth ed. Sunderland, MA USA: Sinauer Associates, Inc.; 2014:476-487. 
37. Slack JMW. Stem cells. In: Essential developmental biology. Third ed. West Sussex, UK: 
Wiley-Blackwell; 2013:343-347. 
38. Nigmatullina L, Norkin M, Dzama MM, et al. Id2 controls specification of Lgr5+ intestinal 
stem cell progenitors during gut development. EMBO J. 2017; 36(7):869-885.  
39. De Santa Barbara P, Van Den Brink GR, Roberts DJ. Development and differentiation of the 
intestinal epithelium. Cell Mol Life Sci. 2003; 60(7):1322-1332.  
40. Merker SR, Weitz J, Stange DE. Gastrointestinal organoids: How they gut it out. Dev Biol. 
2016; 420(2):239.  
41. Takashima S, Gold D, Hartenstein V. Stem cells and lineages of the intestine: A 
developmental and evolutionary perspective. Dev Genes Evol. 2013; 223(0):10.  
42. Hellström A, Ley D, Hansen-Pupp I, et al. Insulin-like growth factor 1 has multisystem 
effects on foetal and preterm infant development. Acta Paediatr. 2016; 105(6):576-586.  
 25 
43. Reilly. Prepubertal expsosure to arsenic(III) suppresses circulating insuling-like growth 
factor-1 (IGF-1) delaying sexual maturation in female rats. 2014. 
44. Gilbert SF. Early zebrafish development. In: Azelie Aquadro, Carol Wigg, Elizabeth C. 
Pierson, eds. Developmental biology. Tenth ed. Sunderland, MA USA: Sinauer Associates, Inc.; 
2014:271-282. 
45. Slack JMW. The zebrafish. In: Essential developmental biology. Third ed. West Sussex, UK: 
Wiley- Blackwell; 2013:107-119. 
46. Rechler MM, Clemmons DR. Regulatory actions of insulin-like growth factor-binding 
proteins. Trends Endocrinol Metab. 1998; 9(5):176-183.  
47. Maures TJ, Duan C. Structure, developmental expression, and physiological regulation of 
zebrafish IGF binding protein-1. Endocrinology. 2002; 143(7):2722-2731.  
48. Azizi S, Nematollahi MA, Mojazi Amiri B, et al. IGF-I and IGF-II effects on local IGF 
system and signaling pathways in gilthead sea bream (sparus aurata) cultured myocytes. Gen 
Comp Endocrinol. 2016; 232:7-16.  
49. Verri T, Terova G, Dabrowski K, et al. Peptide transport and animal growth: The fish 
paradigm. Biol Lett. 2011; 7(4):597-600.  
50. Zhang Y, Viennois E, Zhang M, et al. PepT1 expression helps maintain intestinal homeostasis 
by mediating the differential expression of miRNAs along the crypt-villus axis. Sci Rep. 2016; 
6:10.  
 26 
51. Ng ANY, Jong-Curtain TAd, Mawdsley DJ, et al. Formation of the digestive system in 
zebrafish: III. Intestinal epithelium morphogenesis. Dev Biol. 2005; 286(1):114.  
52. Roach G, Heath Wallace R, Cameron A, et al. Loss of ascl1a prevents secretory cell 
differentiation within the zebrafish intestinal epithelium resulting in a loss of distal intestinal 
motility. Dev Biol. 2013; 376(2):171-186.  
53. Wallace KN, Akhter S, Smith EM, Lorent K, Pack M. Intestinal growth and differentiation in 
zebrafish. Mech Dev. 2005; 122(2):157-173.  
54. Brugman S. The zebrafish as a model to study intestinal inflammation. Dev Comp Immunol. 
2016; 64:82-92.  
55. Liu JT, Bain LJ. Arsenic inhibits hedgehog signaling during P19 cell differentiation. Toxicol 
Appl Pharmacol. 2014; 281(3):243-253.  
56. Hall M, Gamble M, Slavkovich V, et al. Determinants of arsenic metabolism: Blood arsenic 
metabolites, plasma folate, cobalamin, and homocysteine concentrations in Maternal Newborn 
pairs. Environ Health Perspect. 2007; 115(10):1503-1509.  
57. Yorifuji T, Kato T, Ohta H, et al. Neurological and neuropsychological functions in adults 
with a history of developmental arsenic poisoning from contaminated milk powder. Neurotoxicol 
Teratol. 2016; 53:75.  
58. Dakeishi M, Murata K, Grandjean P. Long-term consequences of arsenic poisoning during 
infancy due to contaminated milk powder. Environ Health. 2006; 5:31-069X-5-31.  
 27 
59. Yorifuji T, Matsuoka K, Grandjean P. Height and blood chemistry in adults with a history of 
developmental arsenic poisoning from contaminated milk powder. Environ Res. 2017; 155:86-91.  
60. Rahman A, Vahter M, Smith AH, et al. Arsenic exposure during pregnancy and size at birth: 
A prospective cohort study in bangladesh. Am J Epidemiol. 2009; 169(3):304-312.  
61. Govarts E, Remy S, Bruckers L, et al. Combined effects of prenatal exposures to 
environmental chemicals on birth weight. Int J Environ Res Public Health. 2016;13(5):495.  
62. Ahmed S, Rekha RS, Ahsan KB, et al. Arsenic exposure affects plasma insulin-like growth 
factor 1 (IGF-1) in children in rural bangladesh. PLoS One. 2013; 8(11).  
63. Gardner RM, Kippler M, Tofail F, et al. Environmental exposure to metals and children's 
growth to age 5 years: A prospective cohort study. Am J Epidemiol. 2013; 177(12):1356-1367. 
64. Erickson RJ, Mount DR, Highland TL, et al. The relative importance of waterborne and 
dietborne arsenic exposure on survival and growth of juvenile rainbow trout. Aquatic Toxicology. 
2011. 
65. Rodriguez KF, Ungewitter EK, Crespo-Mejias Y, et al. Effects of in utero exposure to arsenic 
during the second half of gestation on reproductive end points and metabolic parameters in 
female CD-1 mice. Environ Health Perspect. 2016; 124(3):336-343.  
66. Ditzel EJ, Nguyen T, Parker P, et al. Effects of arsenite exposure during fetal development on 
energy metabolism and susceptibility to diet-induced fatty liver disease in male mice. Environ 
Health Perspect. 2016; 124(2):201-209.  
 28 
67. Tolins M, Ruchirawat M, Landrigan P. The developmental neurotoxicity of arsenic: Cognitive 
and behavioral consequences of early life exposure. Ann Glob Health. 2014; 80(4):303-314.  
68. Olivares CI, Field JA, Simonich M, et al. Arsenic (III, V), indium (III), and gallium (III) 
toxicity to zebrafish embryos using a high-throughput multi-endpoint in vivo developmental and 
behavioral assay. Chemosphere. 2016; 148: 361-368.  
69. de Castro MR, Lima JV, de Freitas DP, et al. Behavioral and neurotoxic effects of arsenic 
exposure in zebrafish (danio rerio, teleostei: Cyprinidae). Comp Biochem Physiol C Toxicol 
Pharmacol. 2009; 150(3):337-342.  
70. Dew WA, Veldhoen N, Carew AC, et al. Cadmium-induced olfactory dysfunction in rainbow 
trout: Effects of binary and quaternary metal mixtures. Aquatic Toxicology. 2016; 172:86.  
71. RodrÃguez-Barranco M, LacasaÃ M, Aguilar-GarduÃ C, et al. Association of arsenic, 
cadmium and manganese exposure with neurodevelopment and behavioral disorders in children: 
A systematic review and meta-analysis. Sci Total Environ. 2013; 455:562.  
72. Rocha-Amador, Diana AND Navarro, Maria Elena AND Carrizales, et al. Decreased 
intelligence in children and exposure to fluoride and arsenic in drinking water. 2007.  
73. von Ehrenstein OS, Poddar S, Yuan Y, et al. Children's intellectual function in 
relation to arsenic exposure. Epidemiology. 2007; 18(1):44-51.  
 
 
 
 
 29 
 
 
CHAPTER TWO 
 
EMBRYONIC ARSENIC EXPOSURE REDUCES GROWTH, ALTERS 
FEEDING BEHAVIOR, INTESTINAL STRUCTURE, AND IGF SIGNALING 
PATHWAYS 
Kaleigh C. Sims, Katie L. Schwindinger, Dana B. Szymkowicz, William C. Bridges, Lisa 
J. Bain 
 
 
 
 
 
 
 
 
 
 
 30 
 
Abstract 
Arsenic is found as a contaminant of drinking water, rice, and other crops. 
Epidemiological studies have shown that embryonic exposure to arsenic can cause 
changes in behavior and reductions in growth, but the mechanisms for these effects are 
not well understood. Thus, killifish were exposed to 0, 10, 50, and 200ppb AsIII as 
embryos, and after hatching, were reared in clean water for up to 28 weeks. Growth, 
assessed by condition factor (weight/length3), was significantly reduced in the 200 ppb 
groups at 8 weeks by 24% with a dose dependent increase in 10 and 50 ppb. Significant 
behavioral changes were also noticed at 16 and 28 weeks, including reduced response to 
food.  Additionally, there was a reduction in intestinal villus area and absorptive 
intestinal surface area at 16 weeks. A decrease in liver IGF1 and IGFBP-1 transcript 
levels were observed, particularly a decrease at 8 weeks when there was a reduction in 
condition factor as well and an increase in muscle IGF1 and IGFBP-5.  By 16 and 28 
weeks, there is a shift in that IGF-1 liver and IGFBP-1 increase with arsenic exposure, 
and are highly correlated to one another.  We hypothesize that embryonic exposure to 
arsenic impairs fish’s ability to maximize nutrient intake due to a decreased feeding 
response and reduced numbers of intestinal enterocytes, ultimately causing compensatory 
changes in key proteins of the IGF signaling pathway.   
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1. Introduction 
Arsenic (As) is a naturally occurring element found in water, sediments, and soils, 
with the main route of exposure being drinking water. The most commonly found arsenic 
species in aqueous environments are the inorganic forms, arsenite (AsIII) and arsenate 
(AsV) with arsenite being the predominate species in groundwater1-3. Currently, the 
World Health Organization (WHO) has set the standard for arsenic in drinking water at 
10 ppb, although higher levels of arsenic are found all over the world in countries like 
China, Bangladesh, Hungary, Chile, and Japan2,4-8.  Even in the U.S., arsenic levels above 
10ppb can be found in unregulated wells, exposing roughly 13 million households to high 
arsenic concentrations in their drinking water9. The 10 ppb standard was set to help 
protect people from chronic exposures that can cause cancer and cardiovascular diseases, 
as well as potential developmental problems10,11. Not only is water a concern, but arsenic 
has been found in dietary sources such as wheat bread, rice, milk and dairy products12.  
Arsenic levels in rice, a staple crop for many people, pose a particular problem, as a study 
found levels of 200 µg/kg in brown rice, 130 µg/kg in white rice, and 70 µg/kg in other 
color rice13, 14. Another study investigated arsenic content in 9 different rice-based infant 
snacks and found ranges from 36.5-568 ng/g total as15. These high levels of arsenic 
content in rice and other snacks is alarming considering families that rely on rice a staple 
crop can consume 0.4 kg of rice per day per person and dietary arsenic exposure between 
0.3 and 8 µg/kg body weight/day was estimated to result in a 1% increased risk of lung 
skin and bladder tumors in humans12.  
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Studies have often focused on arsenic as a carcinogen, but less is known about 
embryonic arsenic exposure and its effects on development and growth.  It is known that 
arsenic can cross the placental barrier exposing a developing fetus to this toxicant16, as 
studies have found levels of arsenic in maternal (11.7μg/L) and fetal (15.7μg/L total 
arsenic) blood to be similar17.  A Bangladesh study found that exposure to arsenic (<100 
ppb) during pregnancy was associated with a significant decrease in birth weight with 
each 1µg/L increase in urinary As concentration being associated with a 1.68 g reduction 
in birth weight18. A European study looking at prenatal exposure to chemical mixtures 
found that arsenic was the only chemical in the mixture to have a significant inverse 
correlation to babies’ birth weight, declining 90g as arsenic increased in cord blood 
samples19. Additionally, a study in Bangladesh found that with increasing arsenic levels, 
IGF-1 plasma levels were significantly decreased and correlated with reduced birth 
weight20. In an animal model, mice exposed to 10 ppb As in utero and postnatally 
weighed 18-23% less than the controls up to 42 days of age in female mice21. 
In addition to changes in weight, other studies have found correlations between 
arsenic exposure and behavioral changes, particularly in children. In Bangladesh, a study 
looking at two cohorts of children at age 6 and age 10 found reduced intellectual function 
and performance, and reduced processing speed with arsenic exposures between 5-
50 μg/L during development22.  Even studies on adults in India found that 19% of 
patients aged 18-65 years old who were exposed to 25-900 μg/L arsenic exhibited 
depression and/or anxiety-like behavior23.  Animal models have also supported the trend 
in behavioral alterations. A study found that both adult and juvenile rats exposed to 
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arsenic had increased learning deficits and time required to learn a new task compared the 
unexposed controls24. Additionally, a study looking at photomotor response as a 
behavioral assay in zebrafish embryos exposed to 900-1,000µM As found that the 
arsenic-exposed embryos exhibited hypoactivity25.  Changes in behavior could potentially 
reduce feeding activity, and therefore reduce growth.  
While arsenic’s effects on growth and behavior have been investigated, very little 
is known about its effects on the intestine, a key organ involved in the uptake of arsenic 
from drinking water and food. One study using the HT-29 human intestinal epithelial cell 
line did find that arsenic increased superoxide levels, causing dysregulation of barrier 
functions in epithelial cells26.  Additionally other metals, such as copper, induce oxidative 
stress in fish intestinal enterocytes after in vivo and in vitro exposures27.  
Intestinal development is similar in mammals and fish, although most fish lack 
true crypts and instead have proliferative compartments at the base of the villus28.  The 
morphogenesis of villi and crypts occur by folding of the endodermal epithelium, and 
stem cell markers such as Lgr5 and Ascl1 start to appear in the intervillus region29.  The 
Wnt/β-catenin and Notch signaling pathways are important in the differentiation of the 
intestinal stem cells 29, 30. Like mammals, epithelial cells in zebrafish migrate from the 
base to the tip of the intestinal fold within 5-7 days.  Mechanisms driving intestinal cell 
differentiation appear to be highly conserved in vertebrates, and produce the same main 
cell types:  enterocytes, Goblet cells, and enteroendocrine cells31-33.  Cell division in 
crypts is dependent upon Wnt/β-catenin signaling, in which the Lgr5+ stem cells 
differentiate into progenitor cells.   From the progenitor cells, the Notch ligand Delta 
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turns on transcription factors such as Hes-1 to specify enterocyte fate31, 34 while the Ascl1 
transcription factor plays a role in specification of goblet and enteroendocrine cells35.  
Interestingly, a previous study in our lab found that arsenic exposure decreased 
Ascl1 expression by ~ 4-fold during embryonic stem cell differentiation in vitro, thereby 
reducing the formation of sensory neurons36, 37. Since Ascl1a also plays a crucial role in 
intestinal stem cell differentiation, we hypothesize that arsenic may also impact intestinal 
development in vivo.  Thus, the goal of the current study is to determine the mechanisms 
by which arsenic exposure during embryogenesis permanently impairs growth using 
killifish (Fundulus heteroclitus) as the animal model.  Potential mechanisms that we will 
examine include changes in intestinal stem cell differentiation and structure, changes in 
feeding behavior, and changes in growth factors needed for skeletal muscle proliferation. 
 
2. Methods 
2.1 Killifish collection 
Adult killifish (Fundulus heteroclitus) were collected from the National Estuarine 
Research Reserve (NERR) site in Georgetown, SC using baited minnow traps, and 
housed at Clemson University for the collection of eggs and milt. All fish throughout this 
study were kept on a 16:8 light/dark cycle at 26oC in 18ppt salt water (CoraLife). Adult 
killifish were fed Ziegler Zebrafish food twice a day and maintained until egg and milt 
collection.  
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2.2 Exposure of killifish embryos to arsenic 
Eggs were stripped from 3-4 females and milt collected from 1-2 males to fertilize 
~300 eggs. Fertilized eggs were randomly placed in one of 28 Petri dishes, and the 
process of fertilization continued until each Petri dish contained 80 eggs.  The fertilized 
eggs were continuously exposed to 0, 10, 50, and 200ppb arsenic, as sodium arsenite, 
with 7 replicate petri dishes per concentration. Water changes were done every other day, 
and embryos monitored for viability and hatching daily.  After hatching, the fry were 
placed in 10 gallon tanks with arsenite-free 18 ppt salt water within 24hr of hatching, and 
fed 5% of their estimated body weight per day. Juveniles were fed brine shrimp until ~4 
weeks of age, then were transitioned to pellet food (Zeigler Brothers).  Sampling time 
points were at 8, 16, and 28 weeks of age. 
 
2.3 Assessing arsenic metabolite formation 
          Using the process described above, additional eggs were fertilized and juveniles 
grown up in clean water for 16 weeks to assess arsenic uptake and metabolism.   Fish 
were exposed to 0, 5, or 10ppm arsenic as sodium arsenite (n= 6 tanks per exposure level; 
each tank had 2-3 killifish) for 5 days in a static renewal system.  Fish were fed twice per 
day, and water changes were conducted once a day. Fish were euthanized in buffered 
MS-222, rinsed in clean water, patted dry, and frozen whole at -80oC.  In order to have 
enough tissue mass for speciation, fish from 3 tanks were combined per exposure group, 
giving n=2 replicates per concentration.    The arsenic species in our adult fish food 
(Ziegler Brothers zebrafish pellets) was also determined.  
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All processing and arsenic analyses were conducted by Brooks Applied Labs 
(Bothell, WA).  Fish and food samples were homogenized and digested in nitric acid 
(modified EPA Method 3050B), and total recoverable arsenic performed by inductively 
coupled plasma triple quadrupole mass spectrometry (ICP-QQQ-MS).  Arsenic species 
examined include arsenite, arsenate, monomethylarsonic acid (MMAs), dimethylarsinic 
acid (DMAs), trimethyl arsine oxide, arsenocholine, and arsenobetaine.  Analyses were 
conducted by ion chromatography coupled to an inductively coupled plasma collision 
reaction cell mass spectrometer (IC-ICP-CRC-MS).  Results are presented as the amount 
of each arsenical species per whole body kg wet weight. 
 
2.4 Killifish feeding behavior and growth measurements 
Sampling time points were at 8, 16, and 28 weeks of age.  Two weeks prior to the 
sampling points, feeding behavior was assessed by videotaping fish movement on two 
separate days.  A grid with 5cm rows was placed in the back of each home tank one week 
prior to the start of the test.  Shielding was used to hide the observer from the fish, and 
fish were not fed for 15 hrs prior to the test.  On the day of the test, the normal position of 
fish within the tank was recorded for 15 seconds using a video camera mounted to a 
tripod.  To start the test, zebrafish food pellets (Ziegler) were gently placed in the top of 
the water column, and response of the fish to the food was videoed for 60 seconds. Using 
the recordings, the following parameters were quantified: 1) time for 10% of the fish to 
start moving in response to the stimuli and 2) percentage of fish within each tank 
responding.  The trials were conducted on two separate days, and averaged per tank.   
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At each sampling time point (8, 16, and 28 weeks of age), 5-6 fish per tank were 
euthanized in 1g/L buffered MS-222.  Fish were patted dry, and weight, body length and 
intestinal length measured.  Condition factor (weight/ length3) for each fish was 
calculated, and averaged per tank.  At the 28 week sampling point, when we were able to 
visually determine sex, 3 males and 3 females were sampled per tank, tissue was 
collected, labeled with sex, and kept separate.  Muscle, liver, and anterior intestine were 
collected from 3 of the 6 fish per tank. Tissue samples were stored in RNAlater at -80oC.  
Additional anterior intestine sections taken from the other 3 fish per tank for histology 
were fixed overnight in 10% buffered formalin, dehydrated in graded ethanol, embedded 
in paraffin, cut into 7 µm transverse sections, and placed on slides. 
2.5 Intestinal morphology  
         Morphological changes in the intestines of embryonically exposed fish were 
examined by hematoxylin and eosin (H&E) staining (n=4 fish per exposure per sampling 
time point).  Once gender could be visually confirmed at 28 weeks of age, 2 males and 2 
females per exposure was collected for histology.  Sections were stained with H&E and 
imaged using a Leica ICC50 HD light microscope. ImageJ software (National Institute of 
Health) was used to determine height and width (mm) of 5 villi per field of view. 
2.6 Immunohistochemistry 
      Paraffin embedded intestinal sections (7µm) were examined for markers of absorptive 
enterocytes (gut absorptive cell epitope antibody; Biorbyt, # orb324078), while the 
number of proliferating cells were examined by the expression of proliferating cellular 
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nuclear antigen (PCNA) (Abcam, #ab29).  Sections underwent antigen retrieval in Tris-
EDTA buffer, pH9, and were then quenched with 3% hydrogen peroxide for 10 minutes. 
Blocking was in avidin- biotin (Vector Labs, Burlingame, CA) for 30 minutes and then 
10% horse serum (Vector ABC Elite Kit) for 17 minutes.  After washes, the appropriate 
dilution of primary antibody (PCNA 1:750; absorptive cells 1:400) was added and 
incubated overnight at 4oC.  Tissues sections were then washed and biotinylated 
secondary antibody was added for 30 minutes. Then Vectastain ABC reagent 
(Biotinylated horseradish peroxidase + Avidin DH) was applied to the sections.  
Antibody labeling was detected with Nova Red, and sections were counter-stained with 
hematoxylin if the primary was not nuclear.  Using these antibodies, Goblet cells can be 
clearly identified based upon morphology.  PCNA positive cells were counted per 2 
intervillus regions within field of view at 40X and averaged per villus.  Absorptive 
surface area was quantified by outlining 4 villi per field of view at 10X for absorptive 
surface and determining the percentage of stained cells using ImageJ.  The colors were 
converted to a black and white image so only cytoplasmic staining of the enterocytes 
would be determined. Goblet cells were counted from each of the 4 villi and averaged per 
villus. All sections were averaged within the group, and statistical significance was 
determined by ANOVA followed by Tukey’s.  
2.7 qPCR  
RNA was extracted from liver, muscle, and intestines using TRIZol (Sigma-
Aldrich, St. Louis, MO).  Purity and RNA concentration were determined using a 
NanoDrop Lite ,and 2µg RNA was reverse-transcribed to cDNA using MMLV-RT.  To 
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conduct qPCR, 40ng cDNA, RT2 SYBR Green mix (Qiagen, Alameda, CA), and gene-
specific primers (Table 1) were run in triplicate on a iQ5 thermocycler (BioRad).  For 8 
and 16 weeks, 5 fish per exposure group were randomly selected to run on one plate per 
gene.  At 28 weeks, 5 fish per gender were examined. A 5-point standard curve (10-3 to 
10-7 ng) for each gene was used to determine the efficiency and linearity of each reaction. 
In muscle, levels of insulin-like growth factor-1 (IGF-1), insulin-like growth factor-1 
receptor (IGF-1R),  and insulin-like growth factor binding protein 5 (IGFBP-5) were 
examined.  In the liver, expression of insulin-like growth factor-1 (IGF-1) and insulin-
like growth factor binding protein 1 (IGFBP-1) were examined.   In the intestine, levels 
of the solute carrier SCL15A1b were examined.  Samples were run in triplicate and gene 
expression data was normalized with 18S rRNA as the housekeeper using the 
comparative threshold (Ct) method38.  All comparative threshold averages were 
compared to the control, which was set at a value of 1. 
Primer Forward Reverse           ºC 
18s 5’-TTT CTC GAT TCT GTG GGT GGT GGT-3’ 5’-TAG TTA GCA TGC CGG AGT CTC GTT-3’           60 
IGF-1 5’- AAA CAG ATA AAC CAACAG GCT ATG-3’ 5’-GCA GCT CAC AAC TCT GGA A-3’           54 
IGF-1R 5’-CGT CTT TGA CCA CAC CCT T-3’ 5’-CGC AGA AAT GTA CGT ACC AGA-3’           55 
IGFBP-5 5’GAA GGA CAC TTC TCG GGT TAT G-3’ 5’ TTG CAC TGT TTG CGC TTG-3’           56 
IGFBP-1 5’ CAT GGC TCT GTG CAC TAC AT-3’ 5’ ATC GCG TTA ACT CTG GCT TT-3’           59 
SLC15Alb 5’-CTC CAC AAC CAT CTA CCA CAC-3’ 5’-CTC ATG GCT CGG AAA GTT CA-3’           52 
Table 1. Killifish qPCR primers  
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2.8 Statistical analysis  
         To analyze differences in arsenic metabolites, condition factor, feeding behavior, 
intestinal morphology, SCL15A1b gene expression, number of PCNA+ cells, and the 
number of goblet cells, an ANOVA followed by a Tukey’s (JMP) was used to compare 
differences between exposure groups.  In all cases, a fit model showed there was no 
effect of day, tank, or sex.  For transcript expression in the liver and skeletal muscle, 
multivariate ANOVA was used to test equality of the two variables across the doses.  If 
MANOVA suggested differences in the four doses, multivariate contrasts were used to 
determine significances of the two variable between specific sets of doses. This allowed 
us to determine the exact nature of the dose impact of the two variables being analyzed at 
a given time point.  Data was consider significant if p<0.05. 
3. Results 
 
3.1 DMA and MMA make up a high percentage of arsenic species in killifish 
First, we wanted to 
determine whether killifish 
could metabolize arsenic into 
mono- and dimethylated 
metabolites in a manner similar 
to humans.  Sixteen-week old 
killifish were exposed to 0, 5, or 
10ppm arsenite, and levels of As (III), As (V), monomethylarsonic acid (MMA), 
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dimethylarsinic acid (DMA), and arsenobetaine (AsB) quantified.  AsB was the only 
arsenical species present in the control fish, and its levels did not change due to arsenic 
exposure (average = 417+62g/kg; data not shown).  DMA, MMA, As (III), and As (V) 
were below the detection limits in control fish, and their values increased in a dose-
responsive manner in the 5ppm and 10ppm exposure groups (Figure 1) with DMA 
accounting for 45-61% and MMA accounting for 15-17% of the total arsenicals.  These 
percentages are similar to paired maternal and newborn blood samples exposed to 90ppb 
arsenic in their water, in which 43+9% of total arsenic was as DMA and 31+6% was as 
MMA17.  Note that in (Figure 1) we are looking at whole body levels, rather than blood 
levels, which accounts for some of the variation in MMA and DMA percentages.  The 
adult fish food contains arsenical species, but >98% of them are arsenobetaine and 
arsenocholine, with As (III) levels below the detection limit.  Arsenite in our water is also 
below detection limits (data not shown).  These data indicate that killifish readily 
metabolize arsenic, and can be used as models for human exposures. 
 
3.2 Embryonic arsenic exposure reduces condition factors in 8 week old killifish 
To assess whether embryonic-only arsenic exposure altered growth in juvenile 
and adult killifish, condition factors (CF; weight/length3) were determined.  Killifish 
were exposed as embryos, and after hatching, were grown out in clean water.  No 
differences in hatchling success or survival up to 28 weeks of age were seen (data not 
shown).  At 8 weeks of age, condition factor was significantly reduced at 200ppb by 20% 
compared to the control (Figure 2A).  No difference was found at 16 or 28 weeks among 
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 any of the exposure groups, but there was a slight trend in condition factor reduction at 
16 weeks (Figure 2A).  At 28 weeks, when male and females were combined, there were 
no differences in condition factor (Figure 2C), although decreases can be seen in the 
females when separated from the males.  
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3.3 Embryonic arsenic exposure alters feeding behavior 
Since reductions and trends in condition factors were seen after embryonic arsenic 
exposure, similar to previous studies39, 40, we wanted to examine potential mechanisms 
for the lack of growth.  Since one possibility is that the arsenic-exposed embryos were 
not actively seeking enough food, we assessed differences in feeding behavior.   At 8 
weeks of age, the arsenic-exposed fish appear to take longer to respond to food, with the 
control fish taking an average of 23 seconds to respond to food placed in their tanks and 
the arsenic exposed fish taking an average of 33 seconds, but there were no significant 
differences 
compared to the 
control (Figure 3).  
At 16 weeks of age, 
there was a 
significant 1.7-fold 
increase in the 
average time to start 
a response in the 10 
ppb embryonically-
exposed fish (Figure 
3).  While the 50 and 
200ppb exposure groups also had start time increases of 1.4- to 1.6-fold, there were no 
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significant differences (Figure 3).  At 28 weeks of age, there was a significant 2-fold 
increase in the start time for 200 ppb group, and increases of 1.2- to 1.6-fold time to start 
for the other groups.  Similarly, the percentage of fish responding to food within the first 
minute at 28 weeks of age was decreased in the arsenic exposed groups, ranging from a 
7% to a 20%t decrease (Figure 3).  These data indicate that embryonic arsenic exposure 
can inhibit responsiveness to feeding which could therefore be a potential reason for 
reductions in growth.  
 
 
3.4 Embryonic arsenic exposure reduces intestinal villus height  
Another possible mechanism for the reductions in growth was that embryonic 
arsenic exposure reduced the number of enterocytes or otherwise altered the ability of the 
intestine to absorb nutrients.  To first examine morphometric changes, hematoxylin and 
eosin (H&E) staining was used to quantify average intestinal villus area by multiplying 
height and width (Figure 4A).   No significant differences were found at 8 weeks of age.  
At 16 weeks of age, there is some reduction in villus area, but these differences do not 
persist at 28 weeks of age (Figure 4B).  The reduction in villus area at 16 weeks does 
follow similar trends with reduced SCL15A1b peptide transporter expression (Figure S1. 
supplemental data), which was examined since other studies in mice have seen 
correlations between reduced SCL15A1b peptide transporter expression, reduced villus 
height, and reduced weight gain2 
 
 45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
 46 
3.5 Embryonic-only arsenic exposure reduces number of PCNA (+) cells and 
absorptive surface 
Immunohistochemistry was used to examine the number of proliferating cells 
(Figure 5A), enterocytes, and goblet cells (Figure 5B).  Since a fit model indicated there 
was no significant effect of sex, all data were combined.  The data show that embryonic 
arsenic exposure 
appears to reduce the 
number of 
proliferating cells up 
to 28 weeks after 
exposure, but only a 
trend was found 
(Figure 6).  Similarly, 
the percentage of cells 
labeled as enterocytes, 
were reduced, 
although this was only 
statistically significant 
in the 50ppb exposure 
group at 28 weeks 
(Figure 6B).   There were no differences in the numbers of Goblet cells, which averaged 
3.5-5 cells per villus (Figure 6C). 
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Figure 7. Muscle IGF-1 and IGFBP-5 increase at 8 and 16 
weeks then are reduced by 28 weeks. At each time point 
muscle IGF-1 and IGFBP-5 were quantified using the 
comparative threshold method (2^ddCt). Averages were analyzed 
for significant difference (p<0.05) indicated by (*) using the one-
way ANOVA method (n=5 per exposure per time point).  
A
. 
B
. 
3.6 Embryonic arsenic exposure alters skeletal muscle IGF-1 and IGFBP-5 
transcript expression  
Since few changes were seen in intestinal cells types or morphology, we wanted 
to see if there were changes in genes involved in the IGF-1 pathway as it is a major 
promotor of growth, especially during the juvenile stage. In a previous study, we had 
seen that embryonic arsenic 
exposure at higher 
concentrations and later time 
periods resulted in increased 
expression of muscle IGF-1 and 
IGF-1R39. We wanted to expand 
upon this earlier study by 
examining a more 
comprehensive set of genes, and 
assess whether lower arsenic 
concentrations also resulted in 
the same effect.  Thus, in 
addition to examining muscle 
IGF-1 mRNA levels, we also 
assessed levels of the pro-myogenic 
retention protein IGF binding protein 
-5 (IGFBP-5)41.   At 8 and 16 weeks of grow-out in clean water, muscle IGFBP-5 and 
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Figure 8.  Liver IGF-1 and IGFBP-1 decrease at 8 
weeks and then increase at 16 and 28 weeks. At each 
time point liver IGF-1 and IGFBP-1 were quantified using 
the comparative threshold method (2^ddCt). Averages 
were analyzed for significant difference (p<0.05) indicated 
by (*) using the MANOVA and multivariate contrast. 
 
method (n=5 per exposure per time point). (n= 5 per 
exposure)  
IGF-1 levels increased in the 50 ppb group compared to the control (Figure 7). 
Additionally there was a notable increase in IGFBP-5 at 16 weeks in the 10 ppb.  
However, by 28 weeks, there is a decrease in IGFBP-5 expression in the 10 ppb group, 
along with a trend such that muscle IGF and IGFBP-5 levels are reduced in all exposures 
(Figure 7). No real trends were seen at any time points with IGF-R (data not shown). 
 
3.7 Arsenic exposure alters the correlation between hepatic IGF-1 and IGFBP-1  
Since the liver is the primary 
organ for IGF-1 synthesis, we analyzed 
hepatic IGF-1 levels as well as the 
IGFBP-1 binding protein, which 
sequesters IGF-1 under stress making it 
less bioavailable42.  When the 
relationship between hepatic IGF and 
IGFBP-1 was compared, there is a 
significant correlation between the two at 
the 8 and 28 week time points (r2=0.93 
and 0.98, respectively).  At 16 weeks, the 
correlation is still apparent, but is not 
statistically significant (r2=0.80).  At 8 
weeks, there is a significant reduction in 
IGF-1 and its binding protein at all 
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arsenic exposure groups compared to the control (Figure 8).  At 16 and 28 weeks, the 
comparisons have changed such that hepatic IGF-1 and IGFBP-1 are significantly 
increased at the 200ppb group, and a trend towards increasing expression exists at 10 and 
50ppb at both time points (Figure 8). The pattern in decreasing liver IGF-1 correlates 
with a decreasing condition factor at 8 weeks of age therefore, indicating embryonic 
arsenic exposure could reduce liver IGF-1 in correlation with a reduction in growth 
(Figure 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* * 
* 
* 
Figure 9.  Liver IGF-1 and condition factor decrease at 8 At each 
time point liver IGF-1 quantified using the comparative threshold 
method (2^ddCt). Condition factor and IGF-1 liver Averages were 
analyzed for significant difference (p<0.05) indicated by (*) using the 
MANOVA and multivariate contrast method (n=5 per exposure per 
time point).  
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4. Discussion 
 The results of this study indicate that embryonic arsenic exposure reduces growth 
of killifish early on during juvenile stages. Reductions in feeding behavior and changes in 
IGF signaling pathway transcript levels might be underlying mechanisms as to why 
arsenic can reduce growth long after the exposure has ended.  
 
4.1 Embryonic arsenic exposure reduces growth at early time points  
 A previous study examining embryonic-only arsenic exposure and long term 
growth found that at 16 and 28 weeks, condition factor was reduced in the arsenic-
exposed groups (50 , 200, and 800ppb) and the reduction persisted up to 52 weeks39. 
Additionally, a study looking at earlier time points, but at much higher exposure 
concentrations, found that 800-5000ppb embryonic arsenic exposure reduced weight in 8 
and 16 week old juvenile fish40.  The current study was conducted to assess the 
mechanisms responsible for these changes in growth at more environmentally relevant 
embryonic arsenic exposures.  After analyzing condition factor at 8 weeks, there were 
dose-dependent reductions in all exposure groups, but a significant reduction (24%) was 
only found in the 200 ppb embryonic exposure group.  At 16 weeks, there is a dose-
dependent trend for reduced condition factor.  These findings were expected and indicate 
that embryonic exposure to arsenic can reduce growth and weight gain during the 
juvenile period.  However, by 28 weeks, the females show a reduction in condition factor 
in a dose-dependent manner, but the males actually had an increase in condition factor in 
the exposure groups.  
 52 
These findings are not entirely consistent with our previous study.  However, 
when the food from the previous study was analyzed for specific arsenic species, we 
found it contained small amounts of trivalent arsenic such that a fish at 16 weeks of age 
weighing an average of 0.3g would have received a continuous arsenic exposure 
equivalent to 2.25ppb arsenic, while a 28 week old fish weighing ~1g would have 
received an exposure equivalent to 7.5ppb continuously.  The zebrafish food used in our 
current study had trivalent arsenic levels below the detection limit.  Thus, the earlier 
study may have had more pronounced growth reductions because of continuous exposure 
to arsenite through the diet.   
 In addition, studies have shown that gender differences can impact the toxicity of 
arsenic43, 44.   A recent study looked at gene expression differences in males and females 
in utero exposed to 0.36 µg/L arsenic on average through household tap water.  
Aquaporin 9 (AQP9), a known transporter of trivalent arsenic, was positively correlated 
with maternal urinary arsenic (U-As) levels in female offspring, but not in male 
offspring45.  Additionally, this study examined expression of developmental genes 
involved in the Wnt, Notch, and stem cell regulator pathways and found that genes such 
as LGR5, HES1, GLI3 were negatively associated and IGFBP6 was positively associated 
with AQP9 levels in females. This study suggests that AQP9 transport of inorganic 
arsenic could be a mediator of arsenic’s sex-specific birth weight reductions in females, 
and the investigators hypothesized that estrogen might play a role in facilitating 
transcription of AQP9 in liver cells 45.  Another study found a reduction in birth weight in 
females by 1.5 g per 1µg/L increase in urinary arsenic concentrations, but only a 
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reduction of 0.15 g birth weight in males.  Only female birth weight was positively 
associated with GLI3 and LGR5 and negatively associated with urinary arsenic levels46. 
These finding indicate that exposure to arsenic during early developmental time points 
can have sex- specific outcomes that relate to reductions in birth weight. The reduction in 
condition factor in females in our study is similar to an epidemiology study that looked at 
children exposed in utero to arsenic, and found that 5 years later, there was a significant 
reduction in weight gain and height with 41% of the children being underweight and 33% 
were stunted, and that these effects were most apparent in girls47. Therefore, arsenic 
might inhibit proper growth in females more than it does in males.  
 As growth was reduced at early time points in embryonic-arsenic exposed 
killifish, it was interesting to observe the reduced feeding behavior.  In our study, we 
noticed an increase in time to feed and a decrease in the number of fish actively feeding, 
particularly at 16 and 28 weeks of age.  An increase in the time it takes to start feeding 
could potentially indicate a lack of interest in feeding, decreased olfactory ability to 
detect the food, or hypoactivity. Previous studies have shown that embryonic arsenic 
exposure reduced feeding behavior in killifish at 28 and 40 weeks of age following an 
embryonic exposure of 200 and 800 ppb asrenic39, which is in line with our findings.  
Similarly, a study in rainbow trout found that exposure to cadmium and copper reduced 
the ability of the fish to detect L-alanine, an amino acid that mimics food48, while 
exposure to copper induced apoptosis in salmon olfactory sensory neurons, thereby 
inhibiting behaviors critical to salmon survival such as food detection49.  Indeed, a 
number of investigations have determined that the olfactory epithelium is a target of 
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metal toxicity.  Additionally, a study found that zebrafish embryos exposed to arsenic 
exhibit hypoactivity during embryonic tail flexions from a photomotor response25. While 
we did not quantify normal activity in the embryonically-exposed killifish, we 
hypothesize that arsenic exposure either alters their ability to detect food or reduces their 
normal swimming activity.  These changes in behavior as a result of exposure to 
toxicants can affect the fish’s capacity to feed25, 50, and therefore reduce growth. 
In addition to feeding behavior changes, intestinal morphology and numbers of 
specific cell types might play a role in the ability to uptake nutrients. Indeed, we found a 
reduction in intestinal area in all exposure groups at 16 weeks of age. Intestinal villus 
height was a part of the area calculation and height plays an important role in increasing 
absorptive surface area, which could help increase growth51. Furthermore, proliferating 
cells are essential in the intestine as the cell turnover is typically 5-7 days, at least in 
zebrafish32. In this study, we found a decreasing trend in the number of PCNA cells in a 
dose dependent manner at 8, 16, and 28 weeks. A decreasing trend in PCNA could 
indicate a decreased ability for intestinal cellular proliferation, which is needed to 
maintain the different cell types in the intestine.   
One type of cell is the enterocyte, which make up ~80% of the intestinal epithelial 
cells, and have absorptive functions to take up nutrients53. In our study, we found a 
significant decrease in absorptive surface which is primarily made up of enterocytes, at 
16 weeks of age, but not any other time points. This could be associated with the 
reduction in villus area at 16 weeks as well as a reduction in PCNA cells. If the number 
of cells is decreased from 8-16 weeks, this could indicate that intestinal cells are not 
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proliferating at a sufficient rate, therefore decreasing the size of the villus and 
subsequently the absorptive surface area of enterocytes.  Arsenic has been found to cause 
oxidative damage leading to necrosis in intestinal epithelial tissue in rats exposed to 600 
ppb in the drinking water54.  Overall, the trend in decrease villus height and decrease in 
absorptive surface at 8 and 16 weeks could be a mechanism involved in reducing 
condition factor.  
 
4.3 Arsenic exposure alters insulin-like growth factor (IGF) pathway transcript 
levels 
IGF-1 is an important signaling pathway involved in growth of mammals as well 
as fish that can act in an autocrine, paracrine, and endocrine manner56, 57. IGF-1 mRNA 
expression is modulated by nutrition in a number of fish, and there are strong arguments 
for IGF-1 as a biomarker of growth in fish58.  In several fish studies, IGF-1 mRNA 
expression is directly related to plasma IGF-1 levels59.  Production of IGF-1 protein is 
stimulated by growth hormone (GH) produced by the anterior pituitary gland, which then 
binds to its receptor in the liver to signal hepatic cells to synthesize IGF-1 through the 
JAK/STAT pathway59,60.  Then IGF-1 is distributed to tissue types with IGF-1 receptors 
(IGF-1R) that activate the PI3K-AKT-TOR signaling pathway in the target tissue to 
increase the expression of genes such as myogenic regulator factors, PCNA, and 
myostatin61.  Additionally, in vitro or in vivo treatment of tilapia with estradiol decreased 
IGF-1mRNA in the liver, which could help explain why there might be sex differences in 
growth in the presence of steroid hormones62.  IGF-1 is bound by binding proteins 
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(IGFBP) that either transport IGF-1 to its receptors on target tissue, or bind and sequester 
IGF-1 under stressful conditions such as malnutrition41, 42, 63.  The interesting correlation 
in this study is that at 8 weeks, when there is a dose-dependent decrease in condition 
factor, there is also a significant decrease in liver IGF-1.  Another study found that pre-
pubertal mice exposed to arsenic had reduced circulating levels of IGF-1 64.  While 
hepatic IGF-1 levels follow growth patterns at 8 weeks, when we analyzed 16 and 28 
weeks, there was a shift in the hepatic IGF-1 and IGFBP-1 levels where it was 
upregulated in a dose dependent manner, potentially as a compensatory mechanism to 
catch up in normal growth.   
Our previous study examining embryonically-exposed killifish at 52 weeks of age 
noticed an increase in muscle IGF-1 levels39.  We hypothesized that arsenic had reduced 
liver IGF-1 levels and the fish were compensating by producing more IGF-1 in the 
skeletal muscle.  While the liver is the primary organ of IGF-1 synthesis, other tissues, 
such as skeletal muscle, can produce IGF-1 if under stress or ablation of the primary 
hepatic source of IGF-165.  For muscle IGFBP-5, the promyogenic binding protein in 
muscle that increases IGF bioavailability by greatly increasing IGF-1 half life41, 66, there 
were increases in its transcript levels at 8 weeks in the fish embryonically exposed to 
arsenic. While growth was reduced at 8 week and liver IGF-1 levels were decreased, the 
killifish could have been increasing IGFBP-5 as a compensatory growth mechanism.  By 
28 weeks of age, we noticed a complete shift in that all exposure groups had reduced 
muscle IGF-1 and IGFBP-5 levels and increased liver IGF-1 and IGFBP-1 levels. 
Therefore, this supports the idea that when the main organ of IGF production, the liver, is 
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not synthesizing or producing IGF in adequate amounts, the other tissue trying to grow 
such as muscle will produce it in order to compensate for growth deficits67. Studies have 
shown that in utero arsenic exposure can decrease birth weight which correlates to 
reduced IGF levels20. While we see reduction in growth and hepatic IGF-1 levels early 
on, it appears that embryonic arsenic effects are remediated potentially by compensating 
through increasing local production of muscle IGF until normal hepatic IGF levels are 
restored.   
 
5. Conclusion  
 Embryonic only arsenic exposure can produce reductions in growth during 
juvenile life stages.  Reductions in growth might be due to alterations in feeding 
behavior, reductions in intestinal villus height and absorptive surface, and alterations in 
IGF-1, IGFBP-1, and IGFBP-5 in liver and skeletal muscle at early time points.  This 
could indicate that while arsenic can impair growth early on, the fish may be able to 
overcome its effects at these lower levels of arsenic exposure by increasing the 
production of IGF-1 and IGFBP-5 in skeletal muscle as a growth compensatory 
mechanism.  
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While there is a good amount of literature on arsenic’s effects on growth, there is 
still a need for research on arsenic’s effects during the embryonic and fetal period, along 
with its long term consequences. It is already known that arsenic exposure in utero via 
mother’s ingestion of contaminated water is correlated with reductions in IGF-1 plasma 
levels and weight gain even 4.5 years after exposure 1, 2.  Reductions in plasma IGF-1 
have even been found in other animal models where female rats were exposed to 10 
mg/kg AsIII, which resulted in an average daily intake of 575µg/day per female rat which 
be the equivalent to human daily intake of 57.5 µg based on a 10 fold difference due to 
differences in metabolism of arsenic between humans and rodents 3.  This study found 
that arsenic exposure suppressed circulating levels of IGF-1 and authors hypothesized 
that arsenic exposure reduced hepatocyte viability3.  As IGF-1 regulates growth during 
fetal and postnatal periods, if the liver is damaged through oxidative stress, the secretion 
of hepatic IGF-1 might be impaired3.  Studies have shown that arsenic exposure increased 
levels of MDA in hepatic tissue in brown trout indicating lipid peroxidation from 
oxidative damage4. 
Since arsenic is found all over the world in groundwater at levels that exceed the 
WHO safe drinking water standard of 10 ppb8,9 and can easily cross the placental 
barrier10 exposure to arsenic is of great concern11-14.  A previous study found that arsenic 
levels in the maternal blood (11.7μg/L) and cord blood (15.7μg/L total arsenic) were 
similar when pregnant mothers were exposed to drinking water containing 90.5μg As/L, 
which indicates that the fetus might be readily exposed to arsenic levels that could 
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interfere with growth and development15.  Similar metabolism and methylation pathways 
of arsenic occur in aquatic animals and mammals, but fish tend to accumulate higher 
levels of arsenobetanine and arsenocholine5. Our body burden study removed 
arsenobetanine, which is non-toxic16, and found that when 16 week-old killifish were 
exposed to 5 and 10 ppm arsenic, they accumulate 1429 and 2832 μg/kg respectively.  
Using linear regression, exposures of 10, 50, and 200ppb would result in body burdens 
ranging from 48 – 101.8 μg/kg.  While these levels are of whole body accumulation 
instead of plasma or urine, it still indicates a fairly high body burden.  Typically, a 10-
fold safety factor is used in risk assessment when extrapolating from a surrogate species 
to humans, and another 10-fold safety factor added to account for variability in a 
population.  So, if adverse effects are seen at a 10ppb exposure, and safety factor of 100-
fold is included, the body burden levels which are considered to be protective are in the 
range of 0.4g/kg.  Using the maternal-fetal study above, an exposure of 90μg As/L 
results in 12 μg/L arsenic in the blood, or that approximately 13% of the ingested arsenic 
is accumulated.  Then you can assume if an adult consumes about 3L of 10ppb arsenic 
contaminated water a day, this might yield levels of 4 -5μg/L per kg in both the mother 
and fetus.  Studies have estimated that arsenic exposure between 0.3 and 8 µg/kg body 
weight/day results in a 1% increased risk of lung, skin, and bladder tumors in humans17.  
Additionally, the U.S. Agency for Toxic Substances and Disease Registry’s (ATSDR) 
Minimal Risk Levels (MRLs) for acute oral consumption at 5µg/kg/day and chronic oral 
consumption at 0.3µg /kg/day arsenic as safe doses for infants18. However, our data 
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suggests that these values might not really be protective enough and that drinking water 
standards for arsenic may need to be lowered.  
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APPENDIX A 
Supplementary Figure 1. Arsenics increases SCL15A1b at 8 weeks, a peptide transporter in the 
intestine, after 10ppb embryonic exposure. 
Figure S1. Average SCL15A1b 2^ddCt is compared at 8, 16, and 
28 weeks. 8 week time point show significant increase in the 10 ppb 
when on-way ANOVA was run * p<0.05 compared to control. (n=5 
per exposure for each time point)  
